Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in gene transfer: risk and ethics

Jonathan Kimmelman1

  • 1Clinical Trials Research Group, Biomedical Ethics Unit, Faculty of Medicine, McGill University, 3647 Peel Street, Montreal, QC, Canada H3A 1X1. jonathan.kimmelman@mcgill.ca

BMJ (Clinical Research Ed.)
|January 8, 2005
PubMed
Summary

No abstract available in PubMed .

Keywords:
Biomedical and Behavioral ResearchGenetics and Reproduction

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta-Analysis.

International journal of cancer·2026
Same author

Ten Questions for Ethics Committees Evaluating the Strength of Evidence in Support of Early Phase Trials.

Ethics & human research·2026
Same author

Meta-Analysis of Median Survival Times With Inverse-Variance Weighting.

Statistics in medicine·2026
Same author

Planned time burden for patients participating in phase 2 cancer trials.

The oncologist·2026
Same author

Drug approvals in crowded drug classes potentially reflect efficacy overestimates and false positivity: A portfolio analysis of immune checkpoint inhibitor trials.

Journal of clinical epidemiology·2026
Same author

Early-phase trial efficacy and safety effect estimates regress upon testing in phase 3 trials.

Journal of clinical epidemiology·2026